PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PRECISION GOLD is a prospective, multi-center, single arm, unblinded interventional post market clinical study conducted in Europe. The purpose of the study is to evaluate asymptomatic cerebral embolic (ACE) lesions in subjects with symptomatic paroxysmal atrial fibrillation undergoing ablation with the Pulmonary Vein Ablation Catheter (PVAC) GOLD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation

NCT02463851

Atrial Fibrillation

COMPLETED NA

The Low Voltage Guided Ablation Trial of Persistent Atrial Fibrillation

NCT02732626

Persistent Atrial Fibrillation

COMPLETED NA

Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients

NCT04023461

Atrial Fibrillation Paroxysmal Cardiac Arrythmias

COMPLETED PHASE4

The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation

NCT06557876

Atrial Fibrillation Paroxysmal

RECRUITING NA

Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study

NCT04926142

Patent Foramen Ovale Atrial Fibrillation Stroke

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

10-12 centers in Europe will enroll up to 56 subjects who meet the inclusion/exclusion criteria and provide consent to participate in the study. Subjects will undergo an ablation for paroxysmal AF with the Medtronic PVAC GOLD (CE-Mark). To assess for ACE lesions, pre- and post-ablation procedure cerebral MRIs will be done along with a neurological exam (Mini Mental State Exam). Subjects will be followed for 1 month post-procedure when a repeat MRI and neurological exam will be conducted if the subject had a positive MRI at pre-hospital discharge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ablation / MRI

All subjects will undergo a standard of care ablation procedure for paroxysmal AF with the CE-Marked PVAC GOLD catheter.

MRIs will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at Pre-Discharge will undergo another MRI at the 1 month follow-up visit.

Group Type OTHER

Ablation / MRI

Intervention Type OTHER

All subjects will undergo a standard of care ablation procedure for paroxysmal AF with the CE-Marked PVAC GOLD catheter.

MRIs will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at Pre-Discharge will undergo another MRI at the 1 month follow-up visit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ablation / MRI

All subjects will undergo a standard of care ablation procedure for paroxysmal AF with the CE-Marked PVAC GOLD catheter.

MRIs will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at Pre-Discharge will undergo another MRI at the 1 month follow-up visit.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symptomatic AF (\>/=2 recurrent AF episodes that self terminate or AF \</=48 hours that are cardioverted)
* Documentation of \>/=1 paroxysmal AF events within past year
* AF symptoms (e.g. palpitations, fatigue, exertional dyspnea, effort intolerance)
* Prescribed to vitamin K antagonist (e.g. warfarin/coumadin)
* Age 18-70 years old
* Clinically indicated for a pulmonary vein ablation
* Willing and able to give informed consent
* Willing, able and committed to participate in all study required activities for the duration of the study

Exclusion Criteria

* Diagnosis of persistent or permanent AF
* Prior left atrial ablation
* Presence of intracardiac thrombus
* Contraindicated for vitamin K antagonist
* Prescribed to direct thrombin or factor inhibitors (e.g. dabigatran, rivaroxaban)
* Prescribed to any investigational drug that may confound the study results
* Cardiac valve prosthesis
* Significant congenital heart defect (corrected or not)
* Pulmonary vein stents
* Pre-existing pulmonary vein stenosis
* Cerebral ischemic event (e.g. stroke, TIA) that occurred within 6 months of study consent date
* If female - pregnancy
* Participation in any other cardiovascular clinical study
* Contraindicated for MRI
* Active sepsis
* Blood clotting abnormalities (genetic)
* Presence of left atrial myxoma
* Venous filtering device (e.g. Greenfield filter)
* Invasive cardiac procedure in past 90 days

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No